Literature DB >> 21784042

The genome-wide expression profile of Paeonia suffruticosa-treated cisplatin-stimulated HEK 293 cells.

Sung-Hwa Sohn1, Eunjung Ko, Yunju Jo, Sung-Hoon Kim, Yangseok Kim, Minkyu Shin, Moochang Hong, Hyunsu Bae.   

Abstract

The root cortex of Paeonia suffruticosa Andrews (PS) is a crude Chinese drug used in many traditional prescriptions. This study was conducted to evaluate the recovery mechanisms induced by PS in HEK 293 cells treated with cisplatin. Previous studies revealed that 1μg/ml PS treatment showed greater than 20% recovery of 14μM cisplatin-induced 50% loss of cell proliferation (IC(50)) determined by mitochondrial activity MTS assay in HEK 293 cells (Sohn et al., 2009). In the present study, the effects of PS on gene expression profiles in stimulated HEK 293 cells were evaluated by oligonucleotide microarray and real-time RT-PCR. The results of the microarray analysis and real-time RT-PCR revealed that DNA repair- and cell proliferation-related genes were up-regulated in PS-treated HEK 293 cells. The mechanism responsible for the effects of PS on HEK 293 cells is closely associated with the regulation of DNA repair and cell proliferation. Thus, PS possesses novel therapeutic potential that could be used for the prevention or treatment of cisplatin-induced nephrotoxicity.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Year:  2009        PMID: 21784042     DOI: 10.1016/j.etap.2009.08.001

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  2 in total

1.  Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment.

Authors:  Muhammad Qasim; Hazir Rahman; Michael Oellerich; Abdul R Asif
Journal:  Proteome Sci       Date:  2011-09-20       Impact factor: 2.480

2.  Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.

Authors:  NamHuk Baek; Ok Won Seo; Jaehwa Lee; John Hulme; Seong Soo A An
Journal:  Drug Des Devel Ther       Date:  2016-07-04       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.